Vectored Immunotherapeutics for Infectious Diseases: Can rAAVs Be The Game Changers for Fighting Transmissible Pathogens? is a research paper published in Frontiers in Immunology (2021). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01NS076991-01
National Institutes of Health
Grant: P01HL131471-02
National Institutes of Health
Grant: UG3HL147367-01
National Institutes of Health
Grant: R01HL097088
National Institutes of Health
Grant: U19 AI149646-01
NIAID NIH HHS
Grant: U19 AI149646
NINDS NIH HHS
Grant: R01 NS076991
NHLBI NIH HHS
Grant: UG3 HL147367
NHLBI NIH HHS
Grant: P01 HL131471
National Institutes of Health
Grant: 1R01HL097088-01A2
Next Generation of Recombinant AAV Serotype Vectors for Gene Therapy
National Institutes of Health
Grant: 6U19AI149646-03
An AAV-mediated functional cure and its impact on the reservoir
National Institutes of Health
Grant: 5UG3HL147367-03
Develop combinatorial non-viral and viral CRISPR delivery for lung diseases
National Institutes of Health
Grant: 5R01NS076991-07
Novel Gene Therapy Strategies for Canavan Disease
National Institutes of Health
Grant: 5P01HL131471-02
New Approaches to Gene Therapy for Alpha-1 Antitrypsin Deficiency
FWCI
4.12
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals